Premier Destination for Sophisticated Buyers of Legal Services
Home > Law Firm Profile > People > Lawyer Profile

Dr. Scott A.M. Chambers

  - Lawyer Profile
 



Dr. Scott A.M. Chambers

Dr. Scott A.M. Chambers

Director for Intellectual Property
 
Patton Boggs LLP
8484 Westpark Drive, Suite 900
McLEAN, VIRGINIA 22102
(Fairfax Co.)

Telephone: 703-744-8000
Fax: 703-744-8001
http://www.pattonboggs.com/schambers



Profile Visibility
#132 in weekly profile views out of 1,306 lawyers in McLEAN, VIRGINIA 22102
#60,152 in weekly profile views out of 968,464 total lawyers Overall


Counsel to Counsel participation. View all activity
What is This?




Experience & Credentials
 


Practice AreasIntellectual Property; Biotechnology; Hatch-Waxman; International Trade; Administrative Law
 
EducationGeorge Washington University, J.D., magna cum laude, 1993, Ohio State University, B.S., 1974; Florida State University, Ph.D., 1981; Maxwell School of Citizenship and Public Affairs, Syracuse University, Cert. of Public Admin., 1999
 
Admitted1993, Virginia; 1994, District of Columbia and U.S. Court of Appeals for the Federal Circuit; registered to practice before U.S. Patent and Trademark Office, 1994
 
MembershipsAmerican Bar Association; Giles S. Rich American Inn of Court for Intellectual Property; National Association of Patent Practitioners; Biojudiciary Project; American Intellectual Property Law Association; American Chemical Society.
 
BornMassillon, Ohio
 
BiographyOrder of the Coif. Senior Staff Fellow, National Institutes of Health, 1986-1988. Recipient: William Brinks Olds Hofer Gilson & Lione Scholarship, Excellence in Intellectual Property Law, 1992; Silver Medal, U.S. Department of Commerce, 1999; Recognition Award, National Partnership for Reinventing Government, 1998; Special Achievement and Gainsharing Awards, United States Patent and Trademark Office, 1989-1992. Law Clerk to Judge Randal R. Radar, U.S. Court of Appeals for the Federal Circuit, 1993-1994. Author: "'Written Description' and Patent Examination Under the US Patent and Trademark Office Guidelines," 7 IP Litigator 9, 2001; Chambers, S.A., "Harmonization in Biotechnology Patent Practice," 18 Biotechnology Law Report 517 (1999); "Comments on the Patentability of Certain Inventions Associated with the Identification of Partial cDNA Sequences," 23 AIPLA Q.J. 53, 1995; "The Exhaustion Doctrine in Biotechnology," 35 IDEA 289, 1995. Co-Author: Englund, S.R., Chambers, S.A., and Leary, D.W., "Recent IP Legislation is Most Sweeping in Years," National Law Journal, Jan. 31, 2000 at C18; Kunin, S.G. and Chambers, S.A., "Intellectual Property: The Engine for Health Care Changes in the New Millennium," 5 Journal of Commercial Biotechnology 166, 1998; Linck, N.J. & Chambers, S.A., "Utility in Biotech Patent Applications," 13 Biotechnology 962, 1995. Speaker: The National Academies Committee on Intellectual Property Rights, Exploring Patenting and Licensing for Proteomics Workshop, 2004; "Federal Trade Commission Hearings on Competition and Intellectual Property Law and Policy in the Knowledge-Based Economy," Antitrust Division Roundtables, 2002; "Federal Trade Commission Hearings on Competition and Intellectual Property Law and Policy in the Knowledge-Based Economy," Foundational Issues in Patents and Antitrust, 2002; "Recent Cases Impacting the Biotechnology and Pharmaceutical Sectors in the United States," Second International Conference on Intellectual Property Rights and Biotechnology, Ministry of Economic Affairs, Republic of China (Taiwan), 2001; "Recent Developments in Biotechnology Practice in the United States," Second International Conference on Intellectual Property Rights and Biotechnology, Ministry of Economic Affairs, Republic of China (Taiwan), 2001; "United States Patent Practice for Biotechnological Inventions," Lecture Series to the Taiwanese Biotechnology Examiners and Judges, Ministry of Economic Affairs, Intellectual Property Office, Republic of China (Taiwan), 2001; "'Written Description' and Patent Examination—the U.S. Patent and Trademark Office Guidelines," American Bar Association Intellectual Property Law Spring CLE Program, Washington, D.C., 2000; "The Written Description Guidelines" (1999); New York, New York, "Technology Transfer: Patents, Licenses and Material Transfer Agreements—Too Much of a Good Thing? Or Not Enough?" and "The Business of Invention" (1998); and Houston, Texas, "The Impact of CAFC Decisions on Biotechnology Patent Practice," Biotechnology Industry Organization (BIO), Seattle, Washington, (1997); "Patent Protection for a World Economy," Canadian Ministry for Intellectual Property, Molecular Farming, London, Ontario, (1999); "Patenting Biotechnological Inventions," Industrial College of the Armed Forces, Washington, D.C., (1995-1999); "Patent Appeals Outside and Inside the Agency," Lucent Technologies Conference for Intellectual Property Attorneys, Murray Hill, New Jersey, (1999); "Recent Federal Circuit Opinions Affecting Biotechnology," Washington and the West Seminar, Los Angeles, California, 1999. Featured Speaker: "Intellectual Property Law and TRIPS Compliance," Commercial Law Development Division of the Department of Commerce, Cairo, Egypt, to the Egyptian Judiciary and Government, 2003; Commercial Law Development Division of the Department of Commerce, Cairo and Luxor, Egypt, to the Egyptian Judiciary on Patents and Intellectual Property Law, 2000. Media Panelist, "The Road Betond Proteomics," Drug Discovery Technology 2001, Boston, Massachusetts, 2001. Distinguished Graduate, Police Academy, 1990. Participant, Chair of Government-Academic Partnerships: Bioethics and Genome Research, Federation of American Societies for Experimental Biology, Washington, D.C., 2001. Member: Editorial Board, Biotechnology Law Report; Advisory Board, Patent, Trademark and Copyright Journal.
 
Reported CasesAbbott Laboratories v. Novapharm, Ltd., 323 F.3d 1324 (Fed. Cir. 2003); Emergency Fuel, LLC v. Pennzoil-Quaker State Co., 71 Fed. Appx. 826 (Fed. Cir. 2003); In re Dance, 160 F.3d 1339 (Fed. Cir. 1998); In re Clement, 131 F.3d 1464 (Fed. Cir. 1997); In re Emert, 124 F.3d 1458 (Fed. Cir. 1997); Hoechst-Roussel Pharmaceuticals, Inc. v. Lehman, 109 F.3d 756 (Fed. Cir. 1997); In re Mayne, 104 F.3d 1339 (Fed. Cir. 1997); Merck & Co., Inc. v. Kessler, 80 F.3d 1543 (Fed. Cir. 1996); In re Alton, 76 F.3d 1168 (Fed. Cir. 1996); Honingsbaum v. Lehman, 903 F. Supp. 8 (D.D.C. 1995)
 
ISLN900121478
 


 

Complete a Client Review


Have you recently worked with this lawyer? Share your experience as a Client of this lawyer and complete a Client Review to help others make an informed choice when hiring legal counsel.
 

Professional Networking for Legal Professionals Only


Quickly and easily expand your professional network – join the premier global network for legal professionals only. It's powered by the Martindale-Hubbell database – over 1,000,000 lawyers strong.
Join Now
 


 

Compare this Lawyer

Compare this lawyer to other lawyers in your Watch List.
 

Add lawyer to My Watch List

As a registered user of martindale.com you can add lawyers to your Watch List. You can securely add comments, compare lawyers in your Watch List, and access these lawyers with one click from your martindale.com homepage.